TradingKey

關於 AxoGen Inc 公司

Axogen, Inc. 專注於周圍神經再生和修復技術的科學、開發和商業化。該公司爲外科醫生和醫療保健提供者提供修復解決方案。其產品包括 Avance 神經移植物、Axoguard 神經連接器、Axoguard 神經保護器、Axoguard 神經帽、Axotouch 雙點鑑別器和 Axoguard HA+ 神經保護器。Avance 神經移植物是一種生物活性處理的人類神經同種異體移植物，用於橋接斷裂的周圍神經，而不會產生與第二個手術部位相關的併發症。Axoguard 神經連接器是一種豬粘膜下層細胞外基質接合輔助劑，用於無張力修復斷裂的周圍神經。Axoguard 神經保護器是一種豬粘膜下層 ECM 產品，用於包裹和保護受損的周圍神經並加強神經重建，同時防止軟組織附着。Axotouch 雙點鑑別器用於測量皮膚任何表面積的神經支配密度。

公司簡介

公司代碼AXGN

公司名稱AxoGen Inc

上市日期Dec 17, 1986

CEOMr. Michael Donald (Mike) Dale

員工數量451

證券類型Ordinary Share

年結日Dec 17

公司地址13631 Progress Blvd.

城市ALACHUA

上市交易所NASDAQ Capital Market Consolidated

國家United States of America

郵編32615

電話13864626817

網址https://www.axogeninc.com/

公司代碼AXGN

上市日期Dec 17, 1986

CEOMr. Michael Donald (Mike) Dale

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Erick Wayne Devinney

Chief Innovation Officer

150.41K

-30.16%

Mr. Paul G. Thomas

Independent Chairman of the Board

21.40K

-38.73%

Ms. Lindsey Hartley

Chief Financial Officer

20.76K

--

Mr. Jens Schroeder Kemp

Chief Marketing Officer

12.68K

-54.18%

Mr. Rick Ditto

Vice President - Global Health Economics, Reimbursement & Policy

--

Mr. John H. Johnson

Independent Director

--

Ms. Kathy Weiler

Independent Director

--

Mr. Marc A. Began

Executive Vice President, Chief Compliance Officer, General Counsel

--

Mr. William P. (Bill) Burke

Independent Director

--

Mr. Alan M. Levine

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Erick Wayne Devinney

Chief Innovation Officer

150.41K

-30.16%

Mr. Paul G. Thomas

Independent Chairman of the Board

21.40K

-38.73%

Ms. Lindsey Hartley

Chief Financial Officer

20.76K

--

Mr. Jens Schroeder Kemp

Chief Marketing Officer

12.68K

-54.18%

Mr. Rick Ditto

Vice President - Global Health Economics, Reimbursement & Policy

--

Mr. John H. Johnson

Independent Director

--

收入明細

FY2023

FY2022

暫無數據

地區USD

名稱

營收

佔比

United States

159.01M

0.00%

業務

地區

暫無數據

股東統計

更新時間: 5月17日週六

持股股東

股東類型

持股股東

佔比

First Light Asset Management, LLC

9.82%

BlackRock Institutional Trust Company, N.A.

6.87%

The Vanguard Group, Inc.

5.55%

ArrowMark Colorado Holdings, LLC

3.49%

Morgan Stanley & Co. LLC

3.48%

Other

70.78%

持股股東

佔比

First Light Asset Management, LLC

9.82%

BlackRock Institutional Trust Company, N.A.

6.87%

The Vanguard Group, Inc.

5.55%

ArrowMark Colorado Holdings, LLC

3.49%

Morgan Stanley & Co. LLC

3.48%

Other

70.78%

股東類型

持股股東

佔比

Investment Advisor/Hedge Fund

38.46%

Investment Advisor

27.64%

Hedge Fund

14.22%

Research Firm

5.24%

Individual Investor

4.80%

Pension Fund

0.48%

Bank and Trust

0.32%

Sovereign Wealth Fund

0.17%

Venture Capital

0.05%

Other

8.62%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

352

41.63M

91.41%

-2.42M

2025Q1

357

42.08M

92.45%

-1.70M

2024Q4

343

39.00M

87.97%

-5.62M

2024Q3

323

39.49M

90.05%

-1.54M

2024Q2

302

38.53M

87.94%

-4.16M

2024Q1

307

37.61M

87.02%

-4.05M

2023Q4

318

35.68M

82.81%

-5.15M

2023Q3

322

35.50M

82.64%

-5.39M

2023Q2

319

36.28M

84.47%

-3.01M

2023Q1

324

35.99M

84.11%

-3.05M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

First Light Asset Management, LLC

4.47M

9.82%

-32.58K

-0.72%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.13M

6.87%

+93.19K

+3.07%

Mar 31, 2025

The Vanguard Group, Inc.

2.53M

5.55%

+103.94K

+4.28%

Mar 31, 2025

ArrowMark Colorado Holdings, LLC

1.59M

3.49%

-657.69K

-29.25%

Mar 31, 2025

Morgan Stanley & Co. LLC

1.59M

3.48%

-105.62K

-6.24%

Mar 31, 2025

Soleus Capital Management, L.P.

1.45M

3.18%

-1.51M

-51.08%

Mar 31, 2025

Driehaus Capital Management, LLC

1.17M

2.57%

+217.59K

+22.80%

Mar 31, 2025

Zaderej (Karen L)

1.14M

2.51%

+71.04K

+6.62%

Mar 21, 2024

Geode Capital Management, L.L.C.

1.03M

2.25%

+19.92K

+1.98%

Mar 31, 2025

Assenagon Asset Management S.A.

1.00M

2.2%

+174.68K

+21.13%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

ROBO Global Healthcare Technology & Innovation ETF

1.87%

SPDR S&P Health Care Equipment ETF

1.2%

iShares Neuroscience and Healthcare ETF

1.14%

Fidelity Digital Health ETF

0.89%

Invesco NASDAQ Future Gen 200 ETF

0.45%

AAM Sawgrass US Small Cap Quality Growth ETF

0.44%

Fidelity Enhanced Small Cap ETF

0.13%

Vanguard US Momentum Factor ETF

0.11%

iShares Micro-Cap ETF

0.11%

Franklin US Small Cap Multifactor Index ETF

0.07%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.87%

SPDR S&P Health Care Equipment ETF

佔比1.2%

iShares Neuroscience and Healthcare ETF

佔比1.14%

Fidelity Digital Health ETF

佔比0.89%

Invesco NASDAQ Future Gen 200 ETF

佔比0.45%

AAM Sawgrass US Small Cap Quality Growth ETF

佔比0.44%

Fidelity Enhanced Small Cap ETF

佔比0.13%

Vanguard US Momentum Factor ETF

佔比0.11%

iShares Micro-Cap ETF

佔比0.11%

Franklin US Small Cap Multifactor Index ETF

佔比0.07%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

AxoGen Inc

12.685USD

AxoGen Inc

12.685

概覽

公司

財務